Company intelligence / Profile preview

AntiCancer

San Diego, California, United Statesanticancer.com ↗

Ownership: Private
Development stage: Commercial

Overview

No late-stage clinical trial results reported. The PDOX mouse model has demonstrated high clinical concordance with human tumor behavior and is used by major pharma/biotech companies for drug discovery. The methionine restriction approach has shown promise in preclinical studies across all tested cancers.

Therapeutic areas: Oncology
Modalities: ProteinMouse model technology
Industry: Biotech

Drug pipeline

6 assets

salmonella typhimurium A1-R

Preclinical

5 more assets in the full pipeline.

Request access →

Partnerships

collaborations with major biotechnology companies for furthering research into methionine restriction therapies and commercialization of PDOX models

Beyond the preview

Go deeper on AntiCancer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AntiCancer.

Explore the full profile